Merit Medical's strong financial performance, successful acquisitions, and positive clinical data for the Wrapsody stent graft are likely to boost investor confidence and drive the stock price up. The acquisitions of EsophyX Z+ and Cook Medical's lead management portfolio enhance the company's product offerings, providing long-term growth potential.